Treatment.com International (TSE:TRUE) has released an update.
Treatment.com AI Inc. has launched an upgraded Medical Education Suite (MES) that aims to streamline the administration of clinical exams while enhancing support for medical students. The suite, featuring innovative tools like the AI Patient and OSCE Case Packages, was unveiled at a symposium hosted by the University of Minnesota Medical School.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
